US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 3.6972
  • +0.1172+3.27%
Trading Jun 26 14:46 ET
3.48MMarket Cap0.29P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-98.35%-3.12M
-24.42%-9.45M
44.26%-2.32M
-60.47%-889K
-394.70%-4.67M
18.50%-1.57M
-102.56%-7.6M
-246.55%-4.17M
-3.36%-554K
-33.95%-943K
Net income from continuing operations
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
36.35%-604K
Operating gains losses
-86.79%116K
23.69%-4.26M
---2.71M
---2.57M
--150K
--878K
---5.58M
----
----
----
Other non cash items
-55.30%582K
782.83%4.68M
--377K
--1M
--2M
--1.3M
--530K
----
----
----
Change In working capital
-91.14%340K
-171.08%-290K
-364.06%-911K
-571.08%-391K
-639.79%-2.83M
960.22%3.84M
188.50%408K
179.68%345K
-68.80%83K
-396.12%-382K
-Change in receivables
--0
--0
--13K
--13K
---13K
-114.44%-13K
200.00%90K
--0
--0
--0
-Change in prepaid assets
19.67%-49K
333.33%70K
58.12%-49K
-46.32%51K
1,512.50%129K
-281.25%-61K
-600.00%-30K
-50.00%-117K
131.71%95K
-83.67%8K
-Change in payables and accrued expense
-90.06%389K
-203.45%-360K
-341.13%-1.11M
-1,700.00%-216K
-654.36%-2.94M
1,258.33%3.91M
192.31%348K
236.28%462K
-104.01%-12K
-587.50%-390K
Cash from discontinued investing activities
Operating cash flow
-98.35%-3.12M
-24.42%-9.45M
44.26%-2.32M
-60.47%-889K
-394.70%-4.67M
18.50%-1.57M
-102.56%-7.6M
-246.55%-4.17M
-3.36%-554K
-33.95%-943K
Investing cash flow
Cash flow from continuing investing activities
-3M
0
-1M
0
0
0
Net intangibles purchase and sale
----
---3M
--0
---1M
----
----
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
----
---3M
--0
---1M
----
----
--0
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
46.11%4.53M
-28.60%7.53M
-62.98%3.95M
502.52%479K
0
3.1M
140.61%10.54M
143.32%10.66M
-119K
0
Net common stock issuance
--0
-27.60%7.53M
-62.72%3.87M
--550K
--0
--3.1M
106.05%10.39M
--10.39M
--0
--0
Proceeds from stock option exercised by employees
--4.97M
-99.32%1K
----
----
----
--0
--148K
----
----
----
Net other financing activities
---442K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
46.11%4.53M
-28.60%7.53M
-62.98%3.95M
502.52%479K
--0
--3.1M
140.61%10.54M
143.32%10.66M
---119K
--0
Net cash flow
Beginning cash position
-73.42%1.78M
78.26%6.71M
-25.81%161K
76.52%1.57M
349.32%8.24M
78.26%6.71M
20.15%3.76M
-62.91%217K
-20.61%890K
0.44%1.83M
Current changes in cash
-7.66%1.41M
-267.23%-4.93M
-75.01%1.62M
-109.51%-1.41M
-606.79%-6.67M
179.17%1.53M
366.72%2.95M
104.25%6.49M
-25.56%-673K
-33.95%-943K
End cash Position
-61.22%3.19M
-73.42%1.78M
-73.42%1.78M
-25.81%161K
76.52%1.57M
349.32%8.24M
78.26%6.71M
78.26%6.71M
-62.91%217K
-20.61%890K
Free cash flow
-98.35%-3.12M
-63.92%-12.45M
44.26%-2.32M
-240.97%-1.89M
-606.79%-6.67M
18.50%-1.57M
-102.56%-7.6M
-246.55%-4.17M
-3.36%-554K
-33.95%-943K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -98.35%-3.12M-24.42%-9.45M44.26%-2.32M-60.47%-889K-394.70%-4.67M18.50%-1.57M-102.56%-7.6M-246.55%-4.17M-3.36%-554K-33.95%-943K
Net income from continuing operations 42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K36.35%-604K
Operating gains losses -86.79%116K23.69%-4.26M---2.71M---2.57M--150K--878K---5.58M------------
Other non cash items -55.30%582K782.83%4.68M--377K--1M--2M--1.3M--530K------------
Change In working capital -91.14%340K-171.08%-290K-364.06%-911K-571.08%-391K-639.79%-2.83M960.22%3.84M188.50%408K179.68%345K-68.80%83K-396.12%-382K
-Change in receivables --0--0--13K--13K---13K-114.44%-13K200.00%90K--0--0--0
-Change in prepaid assets 19.67%-49K333.33%70K58.12%-49K-46.32%51K1,512.50%129K-281.25%-61K-600.00%-30K-50.00%-117K131.71%95K-83.67%8K
-Change in payables and accrued expense -90.06%389K-203.45%-360K-341.13%-1.11M-1,700.00%-216K-654.36%-2.94M1,258.33%3.91M192.31%348K236.28%462K-104.01%-12K-587.50%-390K
Cash from discontinued investing activities
Operating cash flow -98.35%-3.12M-24.42%-9.45M44.26%-2.32M-60.47%-889K-394.70%-4.67M18.50%-1.57M-102.56%-7.6M-246.55%-4.17M-3.36%-554K-33.95%-943K
Investing cash flow
Cash flow from continuing investing activities -3M0-1M000
Net intangibles purchase and sale -------3M--0---1M----------0--0--0----
Cash from discontinued investing activities
Investing cash flow -------3M--0---1M----------0--0--0----
Financing cash flow
Cash flow from continuing financing activities 46.11%4.53M-28.60%7.53M-62.98%3.95M502.52%479K03.1M140.61%10.54M143.32%10.66M-119K0
Net common stock issuance --0-27.60%7.53M-62.72%3.87M--550K--0--3.1M106.05%10.39M--10.39M--0--0
Proceeds from stock option exercised by employees --4.97M-99.32%1K--------------0--148K------------
Net other financing activities ---442K------------------------------------
Cash from discontinued financing activities
Financing cash flow 46.11%4.53M-28.60%7.53M-62.98%3.95M502.52%479K--0--3.1M140.61%10.54M143.32%10.66M---119K--0
Net cash flow
Beginning cash position -73.42%1.78M78.26%6.71M-25.81%161K76.52%1.57M349.32%8.24M78.26%6.71M20.15%3.76M-62.91%217K-20.61%890K0.44%1.83M
Current changes in cash -7.66%1.41M-267.23%-4.93M-75.01%1.62M-109.51%-1.41M-606.79%-6.67M179.17%1.53M366.72%2.95M104.25%6.49M-25.56%-673K-33.95%-943K
End cash Position -61.22%3.19M-73.42%1.78M-73.42%1.78M-25.81%161K76.52%1.57M349.32%8.24M78.26%6.71M78.26%6.71M-62.91%217K-20.61%890K
Free cash flow -98.35%-3.12M-63.92%-12.45M44.26%-2.32M-240.97%-1.89M-606.79%-6.67M18.50%-1.57M-102.56%-7.6M-246.55%-4.17M-3.36%-554K-33.95%-943K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg